Clinical Trial Update: Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intramuscular olanzapine depot with placebo in schizophrenia has completed, sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Relprevv (olanzapine pamoate)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED